Form 8-K - Current report:
SEC Accession No. 0001104659-21-062418
Filing Date
2021-05-06
Accepted
2021-05-06 16:22:45
Documents
2
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2115354d1_8k.htm 8-K 22523
2 EXHIBIT 99.1 tm2115354d1_ex99-1.htm EX-99.1 62254
  Complete submission text file 0001104659-21-062418.txt   85860
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 21898157
SIC: 2834 Pharmaceutical Preparations